Instadose Pharma Corp (INSD)
0.00
USD |
OTCM |
May 20, 16:00
Instadose Pharma Total Liabilities (Quarterly): 8.060M for Feb. 28, 2022
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2022 | 8.060M |
| November 30, 2021 | 0.1623M |
| August 31, 2021 | 0.1132M |
| May 31, 2021 | 0.0604M |
| February 28, 2021 | 0.0125M |
| November 30, 2020 | 0.0824M |
| August 31, 2020 | 0.0745M |
| May 31, 2020 | 0.0704M |
| February 29, 2020 | 0.0657M |
| November 30, 2019 | 0.0567M |
| Date | Value |
|---|---|
| August 31, 2019 | 0.0523M |
| May 31, 2019 | 0.0473M |
| February 28, 2019 | 0.0427M |
| November 30, 2018 | 0.0335M |
| August 31, 2018 | 0.0301M |
| May 31, 2018 | 0.0264M |
| February 28, 2018 | 0.026M |
| November 30, 2017 | 0.0131M |
| August 31, 2017 | 0.0088M |
| May 31, 2017 | 0.0049M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0125M
Minimum
Feb 2021
8.060M
Maximum
Feb 2022
0.7382M
Average
0.0681M
Median
Total Liabilities (Quarterly) Benchmarks
| Neovasc Inc (DELISTED) | 22.89M |
| InMed Pharmaceuticals Inc | 2.254M |
| Tetra Bio Pharma Inc | 6.819M |
| Venus Concept Inc | 106.99M |
| Lucy Scientific Discovery Inc | 4.206M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.01M |
| Shareholders Equity (Quarterly) | 27.95M |